芬尼托因缺氧难题揭示了"一个病例报告"
Avinash Khadela1, Bhavarth Dave1, Yatvi Premal1
1Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India.
Journal of pharmacy practice
|June 13, 2024
概括
过量服用芬伊托因 (PHT) 可能会导致动脉衰竭,这是一种罕见的药物不良反应. 这一案例凸显了治疗药物监测 (TDM) 对PHT的重要性,以防止毒性并确保治疗中的患者安全.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
- 药物监督 药物监督 药物监督
背景情况:
- 氨酸 (PHT) 是一种抗药物,具有狭窄的治疗指数,需要治疗药物监测 (TDM).
- 对PHT的不良药物反应 (ADR) 是常见的,但很少报告因芬伊托因诱导的性衰竭.
研究的目的:
- 报告一种因氨酸诱导的性衰竭病例.
- 为了突出TDM对氨酸的重要性.
- 为了提高科学界对这种罕见的ADR的认识.
主要方法:
- 一个16岁的患者的病例报告.
- 临床表现为动力不良,头和吐.
- 磁共振成像 (MRI) 和血清氨酸水平分析.
主要成果:
- 患者呈现出动力不良,头和吐.
- 核磁共振扫描显示了双边侧侧脑脊液 (CSF) 的损伤.
- 血清氨酸水平有毒 (40微克/毫升).
- 停止使用芬伊托因导致ADR逆转.
结论:
- 在这种情况下,性衰竭归因于氨酸毒性.
- TDM对于预防氨酸诱导的副作用至关重要.
- 为了更好地监测患者,需要提高对芬伊托因诱导的动力衰竭的认识.
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
508
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
508
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Seizures: Classification
335
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
335
Arteries of the Lower Limbs
187
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
187
Inborn Errors of Metabolism
155
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
155


